Video
Brain Aneurysms Update | Causes and Risk Factors
Published: February 20, 2020
View Video chevron_right
Featured Neurosciences Videos |view more
Video
Exploring the Role of Immunosuppression in Autoimmunity for MS Patients Amid COVID-19
The spread of the COVID-19 pandemic has caused us to reconsider how we treat our patients with multiple sclerosis (MS) and even the role of immunosuppression in autoimmunity.
Video
Expanding Options for the Management of Multiple Sclerosis
In this podcast, Penn Medicine's Dr. Amit Bar-Or, discusses the latest research furthering our understanding and treatment of multiple sclerosis.
Video
COVID-19 and Neurological Implications | Penn Medicine
Penn Medicine Professor of Neurology, Joseph R. Berger, M.D. discusses the Neurological Implications of COVID-19.
Video
Best Practices for Telemedicine: The Provider and Patient Experience | Penn Medicine
On Thursday, April 23rd, C. William Hanson, MD, Chief Medical Information Officer and Mary Elizabeth Deleener, MBA, BSN, RN, Director of Network Telemedicine at Penn Medicine presented Best Practices for Telemedicine: The Provider and Patient Experience.
Video
Minimally Invasive and Traditional Spine Surgeries - Podcast with Drs. Malhotra and Khalsa
In this interview, Drs. Amrit Khalsa and Neil Malhotra review types of minimally invasive and traditional spine surgeries offered at the Penn Spine Center, identify when to refer your patient, and discuss they decide which types of procedures ...
Video
Brain Aneurysms Update | Treatment and Case Reports
Dr. Omar Choudri, MD, Co-Director of Cerebrovascular & Endovascular Neurosurgery at Penn Medicine, offers and update on the management of patients diagnosed with brain aneurysms and insight on treatment of aneurysmal disease.
Featured Articles & Documents |view more
News
What Happens After COVID-19? Penn Medicine’s New Post-COVID Recovery Clinic Offers Support
While the number of new COVID-19 hospitalizations continue to decline in Pennsylvania and New Jersey, the pandemic is intensifying in some southern and western states.
News
Amit Bar-Or, MD, and Joseph Berger, MD, multiple sclerosis physicians in Penn Medicine’s Department of Neurology, offer a systematic review of disease modifying therapies in MS to assess patient’s risk of magnifying COVID-19 infection, ...
News
Neurogenetics Team Forms with "Tsunami" of Breakthroughs Looming
The wealth of information that’s become available over the last 10 to 20 years coupled with the rapid evolution of the technology that can analyze it has dramatically transformed neurogenetics.
News
Mapping Epileptic Networks with Virtual Cortical Resection
For the approximately 1 million Americans with drug-resistant epilepsy, the availability of new surgical techniques and implantable devices hasn’t improved freedom from seizure after surgery. It’s not for lack of devices, says Brian Litt, ...
News
Realizing the Future of Neurodegenerative Disease Care…Today
Penn Medicine has one of the oldest neuromuscular programs in the nation, and has pioneered many leading-edge diagnostic techniques and treatments available today.
News
Make Way for the Neuro-Immune Revolution
By the time the pharmaceutical industry began exploring B cell depletion as a treatment for relapsing-remitting multiple sclerosis (MS), Amit Bar-Or, MD, FRCPC, was already well on the way with his own B cell research.
Penn Medicine News
